Luminal B Breast Carcinoma C3642346
Luminal B breast cancer is a more aggressive form of hormone receptor-positive breast cancer that tends to grow faster than luminal A. It requires more intensive treatment, often combining chemotherapy with hormone therapy and sometimes targeted drugs. While it has a higher risk of recurrence, advances in treatment have improved outcomes.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Breast mass with rapid growth
Axillary lymphadenopathy
(lymphatic)Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Skin erythema
(integumentary)Nipple retraction
(breast)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Chemotherapy
Anthracycline and taxane-based chemotherapy to address the more aggressive nature of luminal B tumors. Given before or after surgery depending on staging.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Endocrine therapy with CDK4/6 inhibition
Combination of hormone-blocking agents with targeted CDK4/6 inhibitors for enhanced tumor suppression. Standard approach for advanced or high-risk luminal B disease.
Additional treatment options
Surgical resection with nodal assessment
Mastectomy or lumpectomy with comprehensive axillary node evaluation. May include immediate or delayed reconstruction options.
surgicalRadiation therapy
Post-operative radiation to reduce local recurrence, particularly following breast-conserving surgery or with nodal involvement.
procedureIntensive surveillance protocol
Enhanced monitoring protocol due to higher recurrence risk. Includes regular imaging, tumor markers, and organ-specific surveillance for metastatic disease.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Luminal B Breast Carcinoma C3642346?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Luminal B Breast Carcinoma C3642346. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy